The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice

Since the approval of chimeric antigen receptor (CAR) T cell therapy targeting CD19 by the FDA, CAR-T cell therapy has received increasing attention as a new method for targeting tumors. Although CAR-T cell therapy has a good effect against hematological malignancies, it has been less effective agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Liu, Guoping, Liu, Jibin, Yang, Mu, Fu, Juan, Liu, Guodi, Li, Dehua, Gu, Zhangjie, Zhang, Linsong, Pan, Yingjiao, Cui, Xingbing, Wang, Lu, Zhang, Lixin, Tian, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943972/
https://www.ncbi.nlm.nih.gov/pubmed/33738341
http://dx.doi.org/10.1016/j.omto.2021.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943972/
https://www.ncbi.nlm.nih.gov/pubmed/33738341
http://dx.doi.org/10.1016/j.omto.2021.02.013

Ejemplares similares